Jaypirca: A Novel BTK Inhibitor With a Well-Tolerated Safety Profile

Classes Oncology Jaypirca: A Novel BTK Inhibitor With a Well-Tolerated Safety Profile

Instructions

Please Sign in to your account to see the Class.

Dr Chaves showing Jaypirca's Safety profile in patient treated with Mantle Cell Lymphoma